top of page
Nazata Bio
AI digital therapy improving hypertension outcomes.
Lifesciences & Healthtech
Furthr 2025 Cohort - PSSF

Founder(s)
Tom McCarton
CEO
Shane O'Neil
CTO
About
A personalised digital therapeutic for hypertension that uses behavioural science and AI-driven insights to improve adherence to lifestyle changes, helping patients lower blood pressure through tailored diet and exercise interventions while extending the reach of clinical care through an accessible mobile platform.
bottom of page